Marcus Hausch

Company: Guardant Health

Job title: Head of Commercial EUAA

Seminars:

Advancing Precision Oncology in Europe with a Globally Validated Liquid Biopsy – Guardant360 9:40 am

Comprehensive biomarker testing and precision oncology uptake in Europe face adoption challenges due to regulatory, reimbursement and data hurdles Guardant Health’s partnerships with leading cancer centers in the EU have accelerated Guardant360 adoption, expanding access to high-quality testing Guardant’s successful UK pilot with The Royal Marsden demonstrates how local implementation of Guardant360 drives clinical adoption…Read more

day: Day 1 AM